WAVE Clinical Platform vs Rapid SDH
AI Verdict
Choose WAVE Clinical Platform if…
Choose WAVE Clinical Platform if your primary goal is continuous, proactive patient surveillance across multiple units to prevent general patient deterioration. This tool excels at providing early warnings (up to 6 hours in advance) based on predictive analytics of physiological data, enabling timely clinical intervention and enhancing overall patient safety through integrated EMR and mobile alerts.
View WAVE Clinical Platform →Choose Rapid SDH if…
Choose Rapid SDH if your critical need is the immediate and accurate detection of suspected subdural hematomas from CT scans to expedite neurocritical care decisions. This AI module delivers notifications in under a minute, making it ideal for emergency departments and stroke centers where rapid diagnosis of specific acute neurological conditions is crucial for time-sensitive treatment eligibility and intervention.
View Rapid SDH →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | WAVE Clinical Platform | Rapid SDH |
|---|---|---|
| Pricing | Contact for pricing | Contact vendor |
| Deployment | Software platform, leverages existing hospital IT infrastructure, client-server architecture, web-enabled devices. | Cloud-based, On-premise |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | 1 AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Rapid SDHRapid SDH focuses on a highly streamlined and efficient user experience for its specific task, delivering critical notifications in under a minute and integrating seamlessly with existing clinical workflows like PACS, email, and mobile apps. While WAVE Clinical Platform offers comprehensive, continuous monitoring with customizable alarms, Rapid SDH's targeted approach prioritizes rapid and efficient interaction for time-sensitive neurocritical care decisions.
Clinical Value
Rapid SDHRapid SDH offers exceptional clinical value through its rapid and highly accurate detection of subdural hematomas, with a 99% positive predictive value and high sensitivity/specificity, enabling accelerated neurocritical care decisions. Its broader platform has also been instrumental in expanding stroke treatment windows in influential trials. While WAVE Clinical Platform demonstrates significant value in predicting general patient deterioration and reducing unexpected deaths, Rapid SDH's precise, time-critical diagnostic capability for a high-stakes condition provides a more immediate and quantifiable impact on specific patient outcomes.
Pricing & Value
Rapid SDHNeither tool provides transparent pricing, requiring direct vendor contact. However, Rapid SDH explicitly states its HIPAA compliance and the availability of a Business Associate Agreement (BAA) in its structured facts. This upfront transparency regarding crucial compliance aspects adds significant value and reduces uncertainty for potential buyers compared to WAVE Clinical Platform, which requires contacting the vendor for these details.
Enterprise Readiness
Rapid SDHRapid SDH demonstrates strong enterprise readiness by offering flexible deployment options (cloud-based and on-premise) and explicitly confirming HIPAA compliance and BAA availability. While WAVE Clinical Platform is FDA-cleared and integrates with EMRs and existing IT infrastructure, Rapid SDH's clear declaration of deployment flexibility and compliance makes it slightly more adaptable and reassuring for diverse enterprise environments.
Innovation
WAVE Clinical PlatformWAVE Clinical Platform stands out as the 'first FDA-cleared AI patient surveillance system' that uses predictive algorithms to provide early warning of patient deterioration up to six hours in advance. This represents a broader, foundational innovation in continuous, proactive patient monitoring. While Rapid SDH's speed and accuracy in detecting subdural hematomas are impressive, the core AI technology for medical image analysis is a more established field.
Support & Docs
Rapid SDHRapidAI, the company behind Rapid SDH, explicitly offers 24/7/365 customer support globally via email and phone, along with a range of educational resources, guides, and learning materials. In contrast, the provided information for WAVE Clinical Platform does not detail its support structure or documentation availability, making Rapid SDH the clear winner in this dimension due to its transparent and comprehensive support offerings.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | WAVE Clinical Platform | Rapid SDH |
|---|---|---|
| Name | WAVE Clinical Platform | Rapid SDH |
| Company | Excel Medical Electronics | RapidAI (formerly iSchemaView) |
| Tagline | Predicting the preventableu2122 | Where AI meets patient care. |
| Description | The WAVE Clinical Platform by Excel Medical Electronics is the first FDA-cleared AI patient surveillance system that uses predictive algorithms to provide early warning of patient deterioration, integrating with EMRs and mobile devices to enhance clinical decision support and patient safety. | Rapid SDH by RapidAI is an FDA-cleared AI module that rapidly detects suspected acute and chronic subdural hematomas on CT scans, delivering notifications in under a minute to accelerate neurocritical care decisions. |
| Key Features | Always-on remote patient monitoring, Near real-time display of physiologic data, waveforms, and alarms, Predictive analytics for patient deterioration (e.g., Visensia Safety Index), Early warning of patient deterioration (up to 6 hours in advance), Integration with Electronic Medical Records (EMR), Mobile device compatibility for alerts and data display, Customizable alarm management and routing (AlarmNavigator), Risk stratification of patients | AI-powered detection of suspected hemispheric acute and chronic subdural hematoma (SDH), Notifications to clinicians in one minute or less, High positive predictive value (PPV) of 99% (93% sensitivity, 99% specificity) for SDHs >1ml, Integration with Rapid mobile app, PACS, and email for notifications, Part of a comprehensive hemorrhagic and trauma care AI solution (with Rapid ICH and Rapid Hyperdensity), Analyzes non-contrast CT scans, Aids in streamlining decision-making and expediting patient care, Supports identification of treatment eligibility |
| Specialties | Critical Care, Emergency Medicine, Hospital Medicine | Emergency Medicine, Neurosurgery, Radiology |
Videos
Demos, reviews, and walkthroughs featuring WAVE Clinical Platform and Rapid SDH.